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ABSTRACT
Background: The aim of this study was to describe the clinical and microbiological 
characteristics of infective arthritis and to analyze risk factors for Gram-negative bacterial 
infections that cause infective arthritis.
Materials and Methods: Patients admitted between 2009 - 2018 with infective arthritis in a 
single-tertiary hospital were evaluated retrospectively.
Results: A total of 181 patients were enrolled in this study. Of them, 135 were native joint 
infection patients and 46 were prosthetic joint infection patients. The most common site of 
infective arthritis was the knee (63.6%), followed by the shoulder (17.7%), and the hip (9.9%). 
The most frequently identified microorganisms were Staphylococcus aureus (51.1%), followed 
by Streptococci sp. (21.1%), Enterobacteriaceae (8.4%), and coagulase-negative-Staphylococci (CNS; 
8.4%). Infections due to Gram-negative bacteria and fungi made up 13.7% and 3.2% of all 
cases, respectively. Additionally, 20% and 4.2% of the cases involved methicillin-resistant 
S. aureus (MRSA) and MRCNS. We found that bacteriuria, infective arthritis in the hip, and 
steroid use at admission are independent risk factors for Gram-negative bacterial infections.
Conclusion: Infective arthritis with methicillin-resistant microorganisms reached up to 
about 25% in a single-tertiary hospital in Korea. In case of suspected urinary tract infection, 
infective arthritis of the hip joint, or steroid use at admission time among infective arthritis 
patients, empirical treatment covering Gram-negative microorganisms can be considered.
Keywords: Arthritis, infectious; Gram-negative bacterial infections; Methicillin resistance; 
Risk factors
INTRODUCTION
Infective arthritis can rapidly destroy articular cartilage, occasionally resulting in permanent 
joint disabilities. Therefore, appropriate and prompt use of antibiotics is important for 
minimizing its sequelae. Owing to the fact that Staphylococci and Streptococci were the most 
common causative agents of infective arthritis, empirical antibiotic spectrum usually 
include Staphylococci and Streptococci [1-4]. A study in Korea also reported that 20.5% (n = 25) 
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of patients with culture-positive infective arthritis were due to Staphylococcus aureus and 1.6% 
(n = 2) were due to Streptococci [5]. However, an increased frequency of methicillin-resistant 
S. aureus (MRSA) has been reported in various parts of the world [6-10]. According to a 2017 
report from the Korean GlobaL Antimicrobial Resistance Surveillance System (Kor-GLASS), 
53% of S. aureus infections were due to MRSA [11]. This implies that, in Korea, the antibiotic 
susceptibility profiles of microorganisms causing infective arthritis can change. In order to 
develop appropriate strategies for treating infective arthritis, data on the distributions of 
causative pathogens and the prevalence of antimicrobial resistance are required. However, 
data on the pathogen distributions and resistance patterns of pathogens involved in infective 
arthritis are limited in Korea. Therefore, we needed to investigate the current distribution of 
causative microorganisms of infective arthritis in Korean communities.
The proportion of infective arthritis with Gram-negative microorganisms ranged from 5% to 
20% according to previous studies [2-4, 12, 13]. Among Gram-negative bacteria, Escherichia 
coli, Pseudomonas aeruginosa, and Haemophilus influenzae are frequently isolated pathogens in 
cases of infective arthritis. Although elderly or frail individuals, patients with recurrent 
urinary-tract infections, and recent abdominal surgery are considered to be risk factors for 
Gram-negative bacterial infections in cases with infective arthritis, the evidence was not clear 
[14]. Since Gram-positive bacteria are much more prevalent pathogens in infective arthritis 
than Gram-negative bacteria, empirical therapy for infective arthritis usually includes 
antibiotics for Gram-positive bacteria. The risk of inappropriate use of empirical antibiotics 
in Gram-negative bacterial infective arthritis is high. Thus, it is essential to verify risk factors 
of Gram-negative bacteria in order to successfully treat this disease.
This study aims to describe clinical manifestations and microbiological etiology of 




Patients admitted with infective arthritis in a single-tertiary hospital of Korea from January 
2009 to December 2018, were evaluated retrospectively. The study population only included 
adults older than 18 years of age. Each patient was identified with ICD-10 diagnostic codes, 
including M00.00-29, M00.80-99, M01.00-09, M.01.20-69, M01.80-89, and T.84.5. Only 
patients with microorganisms identified from either synovial fluid or blood were included 
and patients with culture-negative infective arthritis were not included in this study. 
Patients with tuberculosis arthritis and brucella arthritis were also excluded. The criteria for 
diagnosis of septic arthritis were derived from those of Newman [15]. Group A was defined 
by identification of microorganisms from synovial fluid or joint tissue, while Group B was 
defined by evidence of joint inflammation and pathogen isolation from blood.
2. Study design and data collection
A retrospective cohort study was conducted in order to determine the clinical characteristics 
and microbiologic etiology of patients with infective arthritis and risk factors for Gram-
negative microorganisms among subjects with infective arthritis. Medical records of patients 
were retrospectively reviewed for the following variables; age at admission, sex, definition 
criteria, underlying immunosuppression, steroid usage (identified when the patients took 
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steroid at the time of admission regardless of dose and duration), comorbid conditions, 
previous history of infective arthritis, healthcare associated infection (defined with at least 
following history: recent antibiotics usage defined when antibiotics was used within 90 days, 
hospitalization for 2 days or more in the preceding 90 days, residence in a long term care 
facility, chronic dialysis within 30 days, and infective arthritis that developed more than 48 
hours after admission, possible risk factors for infective arthritis (history of acupuncture and 
intra-articular injection, recent trauma, recent joint surgery within 90 days, prosthetic joint 
and other site of infections, including bacteriuria, adjacent skin and soft tissue infection, 
and infective endocarditis), presenting symptoms, site of infective arthritis, complications, 
white blood cell count (WBC), red blood cell count, platelet count, erythrocyte sedimentation 
rate (ESR), blood urea nitrate, serum creatinine, aspartate transaminase (AST), alanine 
transaminase (ALT), total bilirubin, albumin concentration, C-reactive protein (CRP), 
analysis of synovial fluid (WBC count, protein concentration, and glucose concentration), 
and results of microbiological analysis.
3. Microbiological tests
Identification testing was performed using the Vitek 2 automated analyzer system 
(bioMérieux, Marcy l'E'toile, France) until 2013. The Bruker Biotyper matrix-assisted laser 
desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) system (Bruker 
Daltonics, Bremen, Germany) was introduced in 2013 and used for identification testing 
from 2013 onwards. All susceptibility testing was performed using the Vitek 2 automated 
analyzer system with a VITEK AST2 N212 card (bioMérieux). Antibiotic susceptibility was 
interpreted using the Clinical and Laboratory Standards Institute (CLSI) criteria [16].
4. Statistical analysis
Pearson's chi-square test was used to compare two variables. Fisher's exact test was used 
instead of Pearson's chi-square test when the expected value of at least one cell is <5. 
Variables of which P-value <0.1 from univariate analysis were included into multivariate 
logistic regression model for determining independent risk factors of infections with Gram-
negative microorganisms. The results of statistical analyses were judged to be significant 
when the P-value was <0.05. Variance inflation factor (VIF) was used to test multi-collinearity. 
VIF >10 was regarded that multi-collinearity exist. Hosmer-Lemshow's test was done to test 
goodness-of-fit. SPSS software, version 23.0 (SPSS, IBM Copr., Armonk, NY, USA), was used 
for all statistical analyses.
5. Ethics approval and consent to participate
Ethical approval was obtained from the institutional review board at Severance Hospital 
(Approval No. 4-2020-1138). The need for patient consent was waived due to the retrospective 
nature of the study.
RESULTS
1. Demographic data
Two hundred and forty eight cases were identified by ICD-10 diagnostic codes and 
culture results. Patients who were not admitted (n = 9), patients with no microbiological 
confirmation (n = 55), and tuberculosis arthritis patients (n = 3) were excluded. Thus, 181 
patients remained and were evaluated in this study. The median age of the subjects was 68.0 
(Range: 55 – 75.5; Table 1). The sex ratio was approximately equal, with 53.0% males. We also 
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compared native joint patients to prosthetic joint patients. The prosthetic joint group was 
generally older than the native joint group, while more men were in the native joint group.
2. Comorbidities and potential risk factors
The most common underlying comorbidities were hypertension (n = 102; 56.4%), followed 
by diabetes mellitus (n = 64; 35.4%), and solid cancer (n = 21; 11.6%; Table 1). There were 
21 cases (11.6%) of patients with previous infective arthritis. Other underlying conditions 
included end stage renal disease (n = 10; 5.5%), liver cirrhosis (n = 6; 3.3%), coronary artery 
disease (n = 16; 8.8%), rheumatologic joint disease (n = 10; 5.6%), hematologic malignancy 
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Table 1. Baseline characteristics of patients with septic arthritis
Number (%)
Total (n = 181) Native joint (n = 135) Prosthetic joint (n = 46) P-value
Demographic data
Age [range], year 68 [55 - 75.5] 66 [54 - 74] 71.5 [63.75 - 78] 0.013
Male 96 (53.0%) 79 (58.5%) 17 (37.0%) 0.011
Comorbidities and underlying conditions
Hypertension 102 (56.4%) 72 (53.3%) 30 (65.2%) 0.160
Diabetes mellitus 64 (35.4%) 51 (37.8%) 13 (28.3%) 0.244
Heart failure 9 (5.0%) 7 (5.2%) 2 (4.3%) 1.000
Coronary artery disease 16 (8.8%) 13 (9.6%) 3 (6.5%) 0.764
Cerebrovascular disease 15 (8.3%) 9 (6.7%) 6 (13.0%) 0.215
COPD 1 (0.6%) 1 (0.7%) 0 (0.0%) 1.000
End stage renal disease 10 (5.5%) 9 (6.7%) 1 (2.2%) 0.456
Liver cirrhosis 6 (3.3%) 6 (4.4%) 0 (0.0%) 0.340
Hepatitis 15 (8.3%) 14 (10.4%) 1 (2.2%) 0.120
Infective arthritis history 21 (11.6%) 10 (7.4%) 11 (23.9%) 0.003
Rheumatologic joint disease 10 (5.6%) 6 (4.4%) 4 (8.7%) 0.278
Solid cancer 21 (11.6%) 19 (14.1%) 2 (4.3%) 0.075
Hematologic malignancy 5 (2.8%) 5 (3.7%) 0 (0.0%) 0.331
Transplantation 5 (2.8%) 3 (2.2%) 2 (4.3%) 0.602
Immunosuppressant 9 (5.0%) 8 (5.9%) 1 (2.2%) 0.452
HIV 1 (0.6%) 1 (0.7%) 0 (0.0%) 1.000
Steroid use 19 (10.5%) 14 (10.4%) 5 (10.9%) 1.000
Long-term care facility 5 (2.8%) 3 (2.2%) 2 (4.3%) 0.602
Recent antibiotics 48 (26.5%) 31 (23.0%) 17 (37.0%) 0.067
Hospital-acquired 9 (5.0%) 8 (5.9%) 1 (2.2%) 0.452
Healthcare-associated 62 (34.3%) 41 (30.4%) 21 (45.7%) 0.059
Definition criteria for infective arthritis
Group A 150 (82.9%) 105 (77.8%) 45 (98.8%) 0.002
Group B 31 (17.1%) 30 (22.2%) 1 (2.2%)
Site of infection
Knee 115 (63.6%) 75 (55.5%) 40 (87.0%) <0.000
Shoulder 32 (17.7%) 32 (23.7%) 0 (0.0%) <0.000
Hip 18 (9.9%) 13 (9.6%) 5 (10.9%) 0.780
Ankle 9 (5.0%) 8 (5.9%) 1 (2.2%) 0.452
Elbow 5 (2.8%) 4 (3.0%) 1 (2.2%) 1.000
Other 9 (5.0%) 9 (6.7%) 0 (0.0%)
Potential risk factors
Prosthetic joint 46 (25.4%) 0 (0.0%) 46 (100.0%)
Bacteriuria 31 (17.1%) 26 (19.3%) 5 (10.9%) 0.192
Intra-articular injection 26 (14.4%) 25 (18.5%) 1 (2.2%) 0.006
Skin and soft tissue infection 22 (12.2%) 19 (14.1%) 3 (6.5%) 0.176
Recent joint surgery 21 (11.6%) 11 (8.1%) 10 (21.7%) 0.013
Acupuncture 12 (6.6%) 11 (8.1%) 1 (2.2%) 0.301
Recent trauma 8 (4.4%) 7 (5.2%) 1 (2.2%) 0.682
Infective endocarditis 7 (3.9%) 7 (5.2%) 0 (0.0%) 0.194
Rheumatologic joint diseases included 8 cases of rheumatoid arthritis, 1 case of ankylosing spondylitis, and 1 case of ulcerative colitis.
COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus.
(n = 5; 2.8%), and transplantation history (n = 5; 2.8%). The number of patients who had 
used any immunosuppressive agent, except steroids, at admission was nine (5.0%). The 
number patients who were actively using steroid was 19 (10.5%).
Healthcare-associated infection occurred in 62 cases (34.3%). Of these cases, 48 (70.6%) 
patients reported previous antibiotics usage, 2 (3.2%) patients had been recently admitted 
to hospital, and 5 (8.1%) patients had been transferred from a long-term care facility. The 
number of patients under chronic dialysis was 10 (16.1%), and the number of patients with 
infective arthritis that had developed in hospital was nine (14.5%).
In Table 1, we described potential risk factors of infective arthritis. The most common risk factor 
was a history of prosthetic joint replacement (n = 46; 25.4%). The second most common risk 
factor was bacteriuria (n = 31; 17.1%), followed by a history of intra-articular injection (n = 26; 
14.4%), adjacent skin and soft tissue infection (n = 22; 12.2%), and recent joint surgery (n = 21; 
11.6%). Bacteriuria was diagnosed upon identification of any microorganisms in urine samples 
that had been collected within 48 hours of admission. The number of patients who had a 
history of acupuncture was 12 (6.6%). There were no cases related to intravenous drug use.
There were no significant differences in comorbidities and risk factors between the native 
joint group and the prosthetic joint group except history of infective arthritis, intra-articular 
injection, and recent joint surgery. More patients with prosthetic joint had history of 
infective arthritis (n = 11; 23.9%) and recent joint surgery (n = 10; 21.7%) than patients with 
native joints (n = 10; 7.4% and n = 11; 8.1%, respectively). On the other hand, intra-articular 
injection history was more frequent in patients with native joint.
3. Symptoms, signs, and investigation at presentation
Median duration from onset of symptoms until admission was 5.0 days (range: 2.0 - 10.0; 
Table 2). Most patients had symptoms and signs of joint inflammation, such as arthralgia (n = 
179; 100%), painful limitation of motion (n = 140; 93.3%), joint swelling (n = 143; 88.8%), and 
local heating sensation (n = 95; 88.8%). Fever was present in 65.7% of the patients and shock, 
defined as a blood pressure below 90/60 mmHg, was present in 12.7% of patients. When 
comparing the native joint group and the prosthetic joint group, there were no significant 
differences in clinical manifestations.
Leukocytosis, defined as blood WBC count above 10.8 × 103/mm3, was recorded in 51.4% (n = 
93) of patients. The average of WBC count was 12002.9 ± 5679.1/mm3. Thrombocytosis was 
recorded in 19.9% (n = 36) of the patients, while thrombocytopenia was recorded in 18.8% 
(n = 34). Serum albumin levels decreased in 66.9% (n = 121) of the patients. ESR (reference 
range: 0.0 - 20.0 mm/hr) and CRP (reference range: 0.0 - 8.0 mg/L) were elevated in most 
of the cases, 96.1% and 97.8% respectively. The average of synovial WBC count was 82,138 ± 
89,448/mm3. The average protein level and glucose level of synovial fluid were 4.3 ± 1.3 g/dL 
and 52.4 ± 58.0 mg/dL, respectively.
We also compared the native joint group with the prosthetic joint group. CRP and ALT were 
higher in the native joint group than in the prosthetic joint group. In the native joint group, 
the median level of CRP and ALT were 180.6 mg/L (range: 88.6 – 276.6 mg/L) and 22.5 IU/L 
(range: 14.0 – 37.0 IU/L), while the median levels were 126.9 mg/L (range: 48.5 – 224.6 mg/L) 
and 17.0 IU/L (range: 10.5 – 30.0 IU/L) in the prosthetic joint group. Other laboratory results 
showed no significant differences between the two groups.
507https://icjournal.org https://doi.org/10.3947/ic.2020.52.4.503
Clinical Characteristics of Infective Arthritis
4. Involved joints
The knees (n = 115; 63.6%) and shoulders (n = 32; 17.7%) were the joints most frequently 
affected, followed by hip joints (n = 18; 9.9%; Table 1, Fig. 1). Of the infected joints, 46 
(24.5%) were prosthetic. Most of the affected prosthetic joints were knee joints (n = 40). Five 
infected hip joints were prosthetic and there was a case of prosthetic ankle joint infection. 
Other joints included sacroiliac joint (n = 4), sternoclavicular joint (n = 2), spine facet joint 
508https://icjournal.org https://doi.org/10.3947/ic.2020.52.4.503
Clinical Characteristics of Infective Arthritis
Table 2. Clinical presentation and laboratory findings of patients with infective arthritis
Number (%)
Total (n = 181) Native joint (n = 135) Prosthetic joint (n = 46) P-value
Clinical presentation
Duration [range], days 5.0 [2.0 - 10.0] 5.0 [2.0 - 8.0] 4.0 [1.0 - 20.0] 0.915
Fever 119 (65.7%) 91 (67.4%) 28 (60.9%) 0.420
Shock 23 (12.7%) 20 (14.8%) 3 (6.5%) 0.145
Arthralgia 179 (100.0%) 133 (100.0%) 46 (100.0%)
Joint swelling 143 (88.8%) 108 (89.3%) 35 (87.5%) 0.775
Local heating sensation 96 (88.9%) 71 (87.7%) 25 (92.6%) 0.726
Painful limitation of motion 140 (93.3%) 106 (93.8%) 34 (91.9%) 0.709
Laboratory findings
WBC count (/mm3) [range] 11,440.0 [7,810.0 - 15,275.0] 11,930.0 [7,930 - 16,050] 11,370.0 [6,825.0 - 14,535.0] 0.347
Hemoglobin (g/dL) [range] 11.5 [10.1 - 13.0] 11.5 [10.1 - 13.0] 11.4 [9.8 - 12.9] 0.647
Platelet count (× 1,000 mm3) [range] 243.0 [169.0 - 384.5] 242.0 [155.0 - 390.0] 263.5 [202.8 - 382.0] 0.331
ESR (mm/hr) [range] 91.0 [63.0 - 116.5] 91.0 [63.0 - 120.0] 89.5 [63.3 - 113.5] 0.759
BUN (mg/dL) [range] 19.2 [13.7 - 29.8] 19.2 [13.5 - 30.8] 20.0 [13.9 - 29.5] 0.966
Creatinine (mg/dL) [range] 0.88 [0.68 - 1.20] 0.89 [0.67 - 1.27] 0.85 [0.71 - 1.14] 0.775
AST (IU/L) [range] 23.0 [16.0 - 39.0] 24.0 [17.0 - 40.0] 21.0 [14.5 - 34.0] 0.267
ALT (IU/L) [range] 21.0 [13.0 - 36.0] 22.5 [14.0 - 37.0] 17.0 [10.5 - 30.0] 0.033
Total bilirubin (mg/dL) [range] 0.6 [0.4 - 0.9] 0.6 [0.4 - 0.9] 0.6 [0.3 - 0.9] 0.265
Albumin (g/dL) [range] 3.1 [2.7 - 3.6] 3.1 [2.7 - 3.5] 3.3 [2.8 - 3.7] 0.141
CRP (mg/L) [range] 169.3 [73.4 - 273.6] 180.6 [88.6 - 276.6] 126.9 [48.5 - 224.6] 0.019
Synovial examination
WBC (/mm3) [range] 50,000.0 [50,000.0 - 100,687.5] 50,000.0 [50,000.0 - 101,700.0] 50,000.0 [31,500.0 - 70,500.0] 0.115
RBC (/mm3) [range] 11,000.0 [3,000.0 - 50,000.0] 10,000.0 [3,000.0 - 46,125.0] 15,000.0 [3,000.0 - 50,000.0] 0.741
Protein (mg/dL), mean ± SD 4,309.99 ± 1,359.30 4,213.81 ± 1,420.60 4,579.31 ± 1,146.53 0.173
Glucose (mg/dL) [range] 32.0 [10.0 - 83.0] 33.0 [10.0 - 87.8] 30.0 [10.0 - 76.0] 0.261
WBC, white blood cell; RBC, red blood cell; ESR, erythrocyte sedimentation rate; BUN, blood urea nitrogen; AST, aspartate transaminase; ALT, alanine 





































Figure 1. Site of infected joint.
(n = 1), and metacarpopharyngeal joint (n = 1). Twelve patients (6.6%) presented with 
multiple joints involvement.
Eighty-seven percentage (n = 40) of prosthetic joint infection patients also had knee joint 
infections, which was more frequent than in the native joint infection group (n = 75; 55.5%; 
P <0.001). All shoulder joint infection cases occurred in the native joint.
5. Distributions of causative microorganisms and antibiotics susceptibility
Ninety-two cases were defined with positive synovial fluid culture alone, while in 58 cases, 
both synovial fluid and blood culture were positive. Additionally, 31 cases were defined with 
blood culture alone. Almost all prosthetic joint infections were defined with positive synovial 
fluid culture results (n = 45; 98.8%), while only 77.8% (n = 105) of native joint infections were 
defined with positive synovial fluid culture. The most commonly identified pathogen was S. 
aureus (n = 97; 51.1%; Table 3). The second most common pathogen was Streptococci (n = 40; 
21.1%), followed by coagulase-negative Staphylococci (n = 16; 8.4%), and Enterobacteriaceae (n = 
16; 8.4%). Pseudomonas sp. made up 2.1% of the cases (n = 4). The number of cases with other 
Gram-positive microorganisms, including Bacillus sp., Enterococci sp., and Micrococcus sp., was five 
(2.6%) and there were six (3.2%) cases of other Gram-negative microorganisms. Other Gram-
negative microorganisms included Burkholderia cepacia, Burkholderia pseudomallei, Acinetobacter 
baumannii, Stenotrophomonas maltophilia, and Achromobacter sp. Overall, 83.2% of the cases were 
caused by Gram-positive microorganisms, while 13.7% of cases were due to Gram-negative 
microorganisms. Only six fungal arthritis cases were identified (Fig. 2). We also analyzed 
the distribution of causative microorganisms by joint type, but there were no differences in 
causative microorganisms between the native joint group and prosthetic joint group.
The number of MRSA were 39.2% (n = 38) of all S. aureus cases and the number of MRCNS 
were 50% (n = 8) of all CNS cases. Among the MRSA cases, 35 cases were healthcare 
associated infections while 61 cases were community-acquired. We also analyzed antibiotic 
resistance profile in accordance with joint type, but there was no significant difference in 
antibiotics resistance profile between overall group, native joint patients, and prosthetic 
joint patients. The proportion of MRSA was higher in healthcare associated infection 
compared with community-acquired infection (odds ratio [OR], 3.185; 95% confidence 
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Table 3. Microorganisms causing septic arthritis
Number of cases (%)
Total (n = 181) Native joint (n = 135) Prosthetic joint (n = 46) P-value Community (n = 119) Healthcare (n = 62) P-value
Gram-positive microorganisms 154 (85.1%) 114 (84.4%) 40 (87.0%) 0.680 107 (89.9%) 47 (75.8%) 0.011
Staphylococcus aureus 96 (53.0%) 73 (54.1%) 23 (50.0%) 0.633 61 (51.3%) 35 (56.5%) 0.507
MRSA 38 (21.0%) 27 (20.0%) 11 (23.9%) 0.574 18 (15.1%) 20 (32.3%) 0.007
CNS 16 (8.8%) 10 (7.4%) 6 (13.0%) 0.243 9 (7.6%) 7 (11.3%) 0.402
MRCNS 8 (4.4%) 5 (3.7%) 3 (6.5%) 0.421 5 (4.2%) 3 (4.8%) 1.000
Streptococci 40 (22.1%) 29 (21.5%) 11 (23.9%) 0.731 35 (29.4%) 5 (8.1%) 0.001
Other Gram-positive 5 (2.7%) 5 (3.7%) 0 (0.0%) 0.331 4 (3.4%) 1 (1.6%) 0.662
Gram-negative microorganisms 25 (13.8%) 19 (14.1%) 6 (13.0%) 0.861 12 (10.1%) 13 (21.0%) 0.044
Enterobacteriaceae 15 (8.3%) 10 (7.4%) 5 (10.9%) 0.536 8 (6.7%) 7 (11.3%) 0.290
Pseudomonas 4 (2.2%) 3 (2.2%) 1 (2.2%) 1.000 1 (0.8%) 3 (4.8%) 0.117
Other Gram-negative 6 (3.3%) 6 (4.4%) 0 (0.0%) 0.340 3 (2.5%) 3 (4.8%) 0.414
Fungal 6 (3.3%) 5 (3.7%) 1 (2.2%) 1.000 2 (1.7%) 4 (6.5%) 0.183
Other Gram-positive microorganisms include E. faecalis, E. avium, E. faecium, Bacillus sp., and Micrococcus sp.; Other Gram-negative microorganisms include 
Stenotrophomonas maltophilia, Burkholderia cepacia, Burkholderia pseudomallei, Acinetobacter maumannii, Achromobacter insolitus, and Achromobacter 
xylosoxidans.
MRSA, methicillin-resistant S. aureus; CNS, coagulase-negative Staphylococci; MRCNS, methicillin-resistant coagulase-negative Staphylococci.
internal [CI], 1.134 - 7.58; P = 0.007; Table 3). Gram-positive microorganisms were identified 
more frequently in community-acquired infection than in healthcare associated infection, 
It was mainly due to Streptococci. The number of cases with Streptococci was 29.4% (n = 35) of 
community-acquired infection cases, while the number was only 8.1% (n = 5) of healthcare 
associated infection cases. In the contrary, Gram-negative microorganisms were more 
frequently cultured in healthcare associated infection. Details of antibiotics susceptibility 
profiles are presented in Tables 4 - 6.
6. Risk factors for Gram-negative organism infection
Univariate analysis of risk factors for infective arthritis caused by Gram-negative 
microorganisms showed association with female sex, solid cancer, previous usage of 
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Figure 2. Distribution of causative microorganisms according to the site of infected joints. 
MSSA, methicillin-sensitive Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus; MSCNS, 
methicillin-sensitive coagulase-negative Staphylococci; MRCNS, methicillin-resistant coagulase-negative 
Staphylococci; Other G+, other Gram-positive microorganisms; Other G-, other Gram-positve microorganisms.
Table 4. Antibiotic resistance rates (%) of Staphylococcus aureus and coagulase-negative Staphylococci causing infective arthritis between 2009 – 2018
Total Native joint Prosthetic joint
Staphylococcus aureus 
(n = 97)
CNS (n = 13) Staphylococcus aureus 
(n = 74)
CNS (n = 7) Staphylococcus aureus 
(n = 23)
CNS (n = 6)
Arbekacin 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Ciprofloxacin 17.5% 38.5% 17.6% 57.1% 17.4% 16.7%
Clindamycin 33.0% 23.1% 32.4% 42.9% 34.8% 0.0%
Linezolid 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Oxacillin 38.7% 61.5% 35.7% 71.4% 47.8% 50.0%
Cefoxitin 39.2% 36.5% 47.8%
Penicillin G 89.7% 92.3% 89.2% 85.7% 91.3% 100.0%
Rifampin 2.2% 0.0% 2.9% 0.0% 0.0% 0.0%
TMP/SMX 2.1% 23.1% 2.7% 42.9% 0.0% 0.0%
Teicoplanin 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Vancomycin 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
The result of susceptibility test for cefoxitin among CNS was omitted, because it was rarely conducted.
CNS, coagulase-negative Staphylococci; TMP/SMX, trimethoprim/sulfomethoxazole. 
steroid, shock at presentation, hip joint infection, shoulder joint infection, bacteriuria, and 
healthcare associated infection (Table 7). A multivariate model identified the following as 
independent risk factors for Gram-negative organism infection: bacteriuria (OR 3.83; 95% 
CI, 1.42 - 10.34; P = 0.008), infective arthritis in hip (OR 3.84; 95% CI, 1.21 - 12.15; P = 0.022), 
and steroid use at admission (OR 3.82; 95% CI, 1.15 - 12.69; P = 0.029; Table 7). VIF showed 
that multi-collinearity didn't exist between each variables (bacteriuria, VIF = 1.02; hip joint 
involvement, VIF = 1.01; steroid use, VIF = 1.01). Hosmer-Lemshow's test showed goodness 
of fit for the multivariate logistic regression model (P = 0.619).
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Table 5. Antibiotic resistance rates (%) of healthcare-associated Staphylococcus aureus and community-acquired 
Staphylococcus aureus causing infective arthritis between 2009 – 2018
Healthcare-associated (n = 35) Community-acquired (n = 62) P-value
Arbekacin 0.0% 0.0%
Ciprofloxacin 34.3% 8.1% 0.001
Clindamycin 42.9% 27.4% 0.120
Linezolid 0.0% 0.0%
Oxacillin 57.1% 27.6% 0.005
Cefoxitin 57.1% 29.0% 0.006
Penicillin G 97.1% 85.5% 0.089
Rifampin 6.7% 0.0% 0.326




Table 6. Antibiotic resistance rates (%) of Enterobacteriaceae causing infective arthritis between 2009 and 2018
Total (n = 16) Native joint (n = 11) Prosthetic joint (n = 5)
Amikacin 0.0% 0.0% 0.0%
Ampicillin 87.5% 100.0% 60.0%
Aztreonam 12.5% 9.1% 20.0%
Ceftazidime 12.5% 9.1% 20.0%
Ciprofloxacin 57.1% 66.7% 50.0%
Ertapenem 0.0% 0.0% 0.0%
Cefepime 12.5% 9.1% 20.0%
Cefoxitin 0.0% 0.0% 0.0%
Cefotaxime 25.0% 27.3% 20.0%
Gentamycin 12.5% 18.2% 0.0%
Imipenem 0.0% 0.0% 0.0%
Levofloxacin 15.4% 22.2% 0.0%
Meropenem 0.0% 0.0% 0.0%
Piperacillin/tazobactam 0.0% 0.0% 0.0%
TMP/SMX 37.5% 54.5% 0.0%
Tigecycline 16.7% 25.0% 0.0%
TMP/SMX, trimethoprim/sulfomethoxazole.
Table 7. Risk factors for infective arthritis due to Gram-negative microorganisms
n Univariate analysis Multivariate analysis
OR (95% CI) P-value OR (95% CI) P-value
Male sex 9/25 (36.0%) 0.45 (0.19 - 1.07) 0.066
Solid cancer 6/25 (24.0%) 2.97 (1.03 - 8.58) 0.048
Steroid use 5/25 (20.0%) 2.54 (0.83 - 7.80) 0.099 3.82 (1.15 - 12.69) 0.029
Shock 6/25 (24.0%) 2.58 (0.91 - 7.36) 0.073
Hip 6/25 (24.0%) 3.79 (1.27 - 11.28) 0.022 3.84 (1.21 - 12.15) 0.022
Shoulder 1/25 (4.0%) 0.17 (0.02 - 1.29) 0.038
Bacteriuria 9/25 (36.0%) 3.43 (1.35 - 8.71) 0.012 3.83 (1.42 - 10.34) 0.008
Healthcare 13/25 (52.0%) 2.37 (1.01 - 5.56) 0.044
OR, odds ratio; CI, confidence interval.
DISCUSSION
In this work, we describe the current distribution of causative microorganisms of infective 
arthritis in Korea. We show, as previous studies have described, that S. aureus and Streptococci 
are still the most common pathogens of infective arthritis [1-4]. The proportion of 
Enterobacteriaceae and CNS was also similar to the aforementioned studies.
In the case of prosthetic joint infections, the distribution of causative microorganisms was 
different from the previous studies. S. aureus and CNS were known to contribute to between 
50 and 60% of prothetic joint infections, and the proportions of prothetic joint infections 
caused by S. aureus and CNS were almost equal [17]. In comparison with the result, our study 
showed that the proportion of CNS was relatively low and that of S. aureus and Streptococci was 
high. This difference seems to be resulted from several limitations of this study. This study 
was conducted in a single tertiary hospital, and since this study is a retrospective study, there 
can also be a possibility that diagnostic codes were missed by clinicians. Those factors seem 
to affect the result of microbiological distribution.
The rate of antibiotic resistance was remarkable in this study. We found that 39.2% of the 
S. aureus cases and half of the CNS cases were methicillin-resistant. Overall, methicillin-
resistant pathogens comprised a quarter of identified microorganisms. Becaure healthcare-
associated infection was as high as 34.3% in this study, the antibiotic resistance rate could 
be overestimated. However, 27.6% of S. aureus cases were methicillin-resistant even in 
community-acquired infections, while 57.1% of S. aureus cases were methicillin-resistant 
in healthcare associated infections. In coagulase-negative Staphylococci infection, 55.6% 
of community-acquired infections and 42.9% of healthcare associated infections were 
methicillin-resistant, respectively. Therefore, we can say that the proportion of methicillin-
resistant pathogens is notably high in infective arthritis not only in healthcare associated 
infections, but also in community-acquired infections.
According to a previous study, published in 2008 in Korea, reported that only 7.4% of 
identified microorganisms were MRSA in 1995 - 2006 [5]. Compared to the study by Seo et 
al. (2008) there has been a notable change in the antibiotic susceptibility of infective arthritis 
in South Korea. Several studies have also reported that the proportion of MRSA in infective 
arthritis increased. In 2005, a study from the United States of America reported 15 out of 
59 septic arthritis cases (25%) involving MRSA [9]. Furthermore, a study from France also 
reported that there was an increased incidence of MRSA infections in 2009 – 2013 (30.8% 
of S. aureus cases) compared to 1979 – 2013 [18]. A study conducted between 2008 and 2011 
in Taiwan, reported that MRSA arthritis was found in 38 (40.9%) cases of S. aureus [7]. Given 
these data, methicillin resistance in infective arthritis seems to be on the rise domestically 
and globally.
Antibiotic resistance in Gram-negative microorganisms was also at a high rate. Although 
the third generation cephalosporins and fluoroquinolone are the commonly used antibiotics 
for Gram-negative microorganisms, the resistance rate of cefotaxime, ciprofloxacin, 
and levofloxacin were 25.0%, 57.1%, and 15.4%, respectively. This trend was especially 
remarkable in healthcare-associated infections. In healthcare-associaed infections, the 
resistance rate of cefotaxime, ciprofloxacin, and levofloxacin rised as high as 57.1% (n = 4), 
75.0% (n = 3) and 33.3% (n = 2).
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A study conducted between 2016 to 2017 in Korea also showed high proportion of antibiotics 
resistance in Gram-negative microorganisms [19]. According to the study, the overall 
cefotaxime resistance rate was 34.7% in E. coli and 27.0% in K. pneumoniae. When it comes to 
healthcare-associated infections, the cefotaxime resistance rate was as high as 55.8% in E. 
coli and 48.2% in K. pneumoniae. Given these findings, we can say that antibiotics resistance 
of Gram-negative microorganisms is serious in infective arthritis, especially in healthcare-
associated infections.
Significantly, in our study, we have also identified independent risk factors of Gram-negative 
infections in infective arthritis. These include bacteriuria, hip joint involvement, and usage of 
steroids. Although old age and frailty, recurrent urinary-tract infection, and recent abdominal 
surgery were previously known risk factors of Gram-negative infections in infective 
arthritis, the evidence was not clear [14]. A study, dealing with asymptomatic bacteriuria 
as a risk factor for prosthetic joint infection, reported that asymptomatic bacteriuria was 
associated with Gram-negative infection in patients with prosthetic joint infection [20]. 
Our study agrees with the findings made by Sousa et al. and demonstrates that bacteriuria at 
admission is a risk factor for Gram-negative infection in prosthetic and native joint infection. 
Since Gram-negative microorganisms were major pathogens of urinary tract infection, 
hematogenous spread of pathogens can explain the association between bacteriuria and 
Gram-negative infective arthritis.
Generally, it is more difficult to perform intraarticular injection in the hip joint than in the knee 
and shoulder joints. In our study, intraarticular injection was performed on only one patient 
out of 18 with hip joint involvement, while 25 of 163 patients with other joint involvement had 
history of intraarticular injection. This suggests that the hip joint is more often involved to 
infective arthritis via hematogenous spread than other joints. Different modes of pathogenesis 
can cause frequent involvement of Gram-negative microorganisms in the hip joints. Whereas, 
frequent Gram-negative infective arthritis in patients who use steroids may be due to the 
immunomodulatory effects of steroids. Given that immunocompromised patients are 
vulnerable to hematogenous spread of microorganisms living in the gastrointestinal tract 
and urinary tract, the immunomodulatory effect of steroids may also encourage the spread of 
Gram-negative microorganisms to the joints. Other immunomodulatory comorbidities and 
underlying conditions, including hematologic malignancy, transplantation, and uses of other 
immunosuppressant were too small in number to compare as risk factors. Thus, additional 
studies with a focus on the effects of other immunomodulatory conditions are in need.
A limitation of our study is that it was a retrospective single center study. There could, 
therefore, be information biased by the nature of a retrospective study. Given that patient 
histories of antibiotics usage were assessed only with in hospital electrical medical records, 
previous antibiotics usage may have been underestimated. Additionally, use of steroids were 
also evaluated with medicine at time of admission. The fact that our study was carried out 
in one tertiary hospital was also a limitation. This hospital, Severance Hospital, is one of 
the biggest hospitals in Korea, which has over 2,000 beds. Traditionally, there has been a 
tendency to refer severely ill patients to this hospital. Thus, it is possible that our study is not 
representative of the entire Korean population. Further prospective multicenter studies are 
needed to confirm the result of our work.
In conclusion, infective arthritis with methicillin-resistant microorganisms reached up to 
about 25% in a single-tertiary hospital in Korea. When urinary tract infection is suspected, 
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infective arthritis occurs in the hip joint, or in patients who are using steroids among infective 
arthritis patients, empirical treatment covering Gram-negative organism can be considered.
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